XML 114 R98.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Segment Reporting Information [Line Items]                      
Revenues $ 4,036,400 $ 4,153,700 $ 4,163,600 $ 3,889,900 $ 3,758,400 $ 3,789,900 $ 3,421,400 $ 3,038,900 $ 16,243,587 $ 14,008,586 $ 11,053,743
Net investment income                 55,494 45,166 69,613
Administrative services fees and other income                 6,294 (1,725) 34,791
Interest Expense                 33,309 31,376 32,614
Depreciation and amortization                 22,533 29,786 38,589
Share-based compensation expense                 29,451 28,334 29,930
Segment pretax income (loss) 101,500 [1],[2] 153,300 [3],[4] 132,100 [5],[6] 67,700 [7],[8] 16,300 [9],[10] 22,700 [11],[12] 98,800 [13] 62,000 [14] 454,644 199,792 269,953
Net income (loss) $ 37,100 [1],[2] $ 60,300 [3],[4] $ 58,400 [5],[6] $ 30,000 [7],[8] $ 4,900 [9],[10] $ (8,900) [11],[12] $ 120,900 [13],[15] $ 28,800 [14] 185,677 145,629 170,126
Corporate/Other/Eliminations [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 0 0 0
Net investment income                 0 0 0
Administrative services fees and other income                 0 0 0
Interest Expense                 0 0 0
Depreciation and amortization                 500 100 0
Share-based compensation expense                 0 0 0
Segment pretax income (loss)                 (118,200) (185,300) (12,000)
Net income (loss)                 (72,800) (41,900) (7,300)
Operating Segments [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 16,181,800 13,965,200 10,949,400
Operating Segments [Member] | Western Region Operations [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 15,553,300 13,361,200 10,377,100
Net investment income                 55,500 45,200 69,600
Administrative services fees and other income                 6,300 (1,700) 34,800
Interest Expense                 33,300 31,400 32,600
Depreciation and amortization                 22,000 29,700 38,600
Share-based compensation expense                 26,500 25,000 26,100
Segment pretax income (loss)                 547,400 315,600 207,500
Net income (loss)                 244,300 146,200 133,900
Operating Segments [Member] | Government Contracts [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 628,500 604,000 572,300
Net investment income                 0 0 0
Administrative services fees and other income                 0 0 0
Interest Expense                 0 0 0
Depreciation and amortization                 0 0 0
Share-based compensation expense                 3,000 3,300 3,800
Segment pretax income (loss)                 25,400 69,500 74,500
Net income (loss)                 14,200 41,300 43,500
Intersegment eliminations [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 0 0 0
Intersegment eliminations [Member] | Western Region Operations [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 13,800 12,400 11,100
Intersegment eliminations [Member] | Government Contracts [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 0 0 0
Intersegment eliminations [Member] | Corporate/Other/Eliminations [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 $ (13,800) $ (12,400) $ (11,100)
[1] Includes $22.7 million in pretax expenses primarily related to the Cognizant Transaction.
[2] Includes $58.2 million amortization of deferred costs of health insurer's fee and $21.1 million in other ACA fees.
[3] Includes $21.7 million in pretax expenses primarily related to the Cognizant Transaction.
[4] Includes $58.4 million amortization of deferred costs of health insurer's fee and $22.2 million in other ACA fees.
[5] Includes $26.4 million in pretax expenses primarily related to the Cognizant Transaction.
[6] Includes $58.5 million amortization of deferred costs of health insurer's fee and $21.5 million in other ACA fees.
[7] Includes $1.9 million pretax asset impairment and $44.3 million in pretax expenses primarily related to the Cognizant Transaction.
[8] Includes $57.8 million amortization of deferred costs of health insurer's fee and $20.8 million in other ACA fees.
[9] Includes $3.8 million pretax asset impairment primarily related to our assets held for sale in connection with the Cognizant Transaction and $68.3 million in pretax expenses primarily related to the Cognizant Transaction.
[10] Includes $35.4 million amortization of deferred costs of health insurer's fee and $25.8 million in other ACA fees.
[11] Includes $31.9 million amortization of deferred costs of health insurer's fee and $26.6 million in other ACA fees.
[12] Includes $84.7 million pretax asset impairment related to our assets held for sale in connection with the Cognizant Transaction and $21.1 million in pretax expenses primarily related to the Cognizant transaction.
[13] Includes $37.8 million amortization of deferred costs of health insurer's fee and $22.5 million in other ACA fees.
[14] Includes $36.3 million amortization of deferred costs of health insurer's fee and $22.5 million in other ACA fees.
[15] Includes tax benefit of $72.6 million, net of adjustments, as a result of a loss on the stock of one of our subsidiaries.